Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AlonSource Group is a private U.S. regenerative medicine and medical products company focused on human tissue allografts and related surgical products. The company markets amnion-derived allografts for wound covering, protection, healing, and repair, as well as demineralized bone matrix and other products used in orthopedic, spine, sports medicine, urology, and OB/GYN settings. Its website positions the business as a commercial supplier to surgeons and physicians rather than a drug-development biotech with a clinical pipeline. Known branded products include amniotic-fluid and amniotic-tissue offerings such as AmnioELITE, AmnioFLEX, and ASGFluid. The company also uses the trade name Surgilogix.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AlonSource Group.